Janice Reed

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy

Rachid Baz, Esteban Walker, Mohamed A. Karam et al. · Annals of Oncology · 2006 · 144 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase 2 Study of Pegylated Liposomal Doxorubicin, Vincristine, Decreased-Frequency Dexamethasone, and Thalidomide in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma

Mohamad A. Hussein, Rachid Baz, Gordan Srkalović et al. · Mayo Clinic Proceedings · 2006 · 108 citations

Medicine, Oncology, Pharmacology +16

Daratumumab proves safe and highly effective in <scp>AL</scp> amyloidosis

Jack Khouri, Andrew Kin, Bicky Thapa et al. · British Journal of Haematology · 2018 · 52 citations · Full text

Life Sciences, Hematology, Immunology +12

Efficacy and Safety Results with the Combination Therapy of Arsenic Trioxide, Dexamethasone, and Ascorbic Acid in Multiple Myeloma Patients: A Phase 2 Trial

Rony M. Abou-Jawde, Janice Reed, Megan Kelly et al. · Medical Oncology · 2006 · 40 citations

Medicine, Oncology, Pharmacology +16

The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma.

Rony M. Abou-Jawde, Rachid Baz, Esteban Walker et al. · PubMed · 2006 · 36 citations

Medicine, Ethnic Studies, Oncology +15